About this event
KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US
Measures Taken for Improving Biosimilar Uptake and the Potential Role of Healthcare Providers and Patients
Wednesday, 29 June 2022 | 10:00 am – 12:00 pm (EDT)
Online event hosted by the Alliance For Safe Biologic Medicines and Generics and Biosimilars Initiative
Biosimilars have been in the market for 16 years since its first launch in 2006 in Europe, currently, there are 84 approvals in the EU and 35 in the US, representing almost 90% of the world market. While more biosimilars entering the healthcare system, there remains the need for broader information share and regular discussions to clarify and alleviate the concerns of biosimilars use for physicians and patients, specifically on the issues of prescribing practice and switching of biosimilars.
An academic clinician with specialty in gastroenterology, a pharmacist, a patient advocate and a market access expert will share their experience with biosimilars, highlighting successes and challenges, their perspectives on prescribing and switching of biosimilars and measures to increase biosimilar adoption, including the role of healthcare providers.
Enhanced knowledge on biosimilars use will help provide more affordable treatment choices for patients.
Keynote speaker:
Impact of biosimilars in the US healthcare system and the path forward
Eric David Hargan, JD, Former United States Deputy Secretary of Health and Human Services
Moderator:
Steven Stranne, MD, JD, Foley Hoag LLP
Speakers:
Eric David Hargan, JD
Michael S Reilly, Esq
Ralph McKibbin, MD, FACP, FACG, AGAF
Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP
Chad Pettit, MBA
Andrew Spiegel, Esq
To find out more about the webinar, click here to download the agenda
Don't miss out on this first ASBM/GaBI biosimilars event, REGISTER NOW!
Hosted by
-
Team member
Anthika GaBI Team memberAG T
-
Guest speaker
Michael S Reilly, Esq Executive Director @ Alliance for Safe Biologic MedicinesG
-
Guest speaker
Chad Pettit, MBA Executive Director, Marketing, Biosimilars Business Unit @ AmgenG
-
Guest speaker
Eric David Hargan, JD Former Deputy Secretary @ Department of Health and Human Services (HHS)G
-
Guest speaker
Philip Schneider Professor @ The Ohio State University College of PharmacyG
-
Guest speaker
Andrew Spiegel Board Chair @ World Patients AllianceG
-
Guest speaker
Steven Stranne, MD, JD Partner @ FOLEY HOAG LLPG
-
Team member
SafeBiologics and GaBI 2022 Webinar Program CommitteeT
-
Guest speaker
Ralph McKibbin, MD, FACP, FACG, AGAF President @ Pennsylvania Society of Gastroenterology/Digestive Disease National CoalitionG
SafeBiologics and GaBI
Building trust in cost-effective treatmentsThe mission of GaBI is to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care.
